Global Cell Isolation Market - 2022-2029

Global Cell Isolation Market - 2022-2029

Market Overview

Cell Isolation Market is expected to grow at a high CAGR of 17.2% during the forecasting period (2022 - 2029).

Cell isolation (or cell separation) is a process used for sorting cells from a heterogeneous group of cells into the specific populations without contamination. This technique helps many cell-based therapies to improve the quality of the treatment. Cell isolation techniques are widely used for biomolecule isolation for the production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Market Dynamics

The global Cell Isolation market growth driven by certain factors such as rising prevalence of chronic diseases with growing geriatric population, technological advancement in cell isolation, increasing demand for biopharmaceuticals, and increasing stem cell research. are among the key factors driving the market growth.

Rising prevalence of chronic diseases, is expected to drive the global cell isolation market during the forecast period

According to the World Health Organization (WHO), cancer accounts for 13% of deaths globally every year. Moreover, a 70% increase in cancer incidences is anticipated over the next couple of decades and the global geriatric population, as they are more prone to cancer, is anticipated to nearly double from 12% to 22%, from 2015 to 2022. By region, cancer incidence is highest in Asia compared to other regions. Contextually, the incidence population of cancers in Asia was 6.67 million in 2012 and is anticipated to reach 10.84 by 2030. The cancer incidence in Asia is higher compared to the cumulative incidence population of all other regions. In terms of growth rate too, the incidence rate of cancers is growing at a notable CAGR of 2.7% in this region. Europe has the second-highest cancer incidence, followed by North America. In terms of the increase in cancer incidence, Europe is anticipated to have the slowest growth in the forecast period. In terms of growth of cancer incidence, Middle and North Africa and South America are considered to the top two regions with CAGR of 3.1% and 2.9%, from 2012 to 2030, respectively. Hence, with the rising prevalence of cancer globally is driving the growth of the cell isolation market.

Stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research hampering the growth of the cell isolation market

However, the cell isolation market is hampered by several factors such as stringent regulations, high cost of cell isolation instruments, and ethical issues related to embryonic stem cell research. Cell biology research necessitates the use of animals and humans. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs, which may harm animals and humans. Also, stem cell research studies use human embryos for clinical applications that often lead to the destruction of embryos. Monitoring of such activities requires stringent regulations which are implemented by regulatory bodies globally. Some of the regulating authorities include Central Ethics Committee for Stem Cell Research (ZES), Human Fertilization and Embryology Authority (HFEA), Human Tissue Authority (HTA), Medicines and Healthcare Products Regulatory Agency (MHRA) and, among others. Hence, with the presence of such ethical concerns and restrictions on the use of cells for research is limiting cell biology research.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research and development to find solutions which can minimize the symptoms of coronavirus at early stages. These ongoing clinical trials and research is expected to increase the demand for cell isolation products, and hence driving the market growth.

Industry Analysis

The global cell isolation market provides in-depth analysis of the market based on various industry factors such as porter’s five force analysis, supply chain analysis, regulatory analysis, pricing analysis, unmet needs.

Segment Analysis/B>

The consumables segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The consumables segment accounted for the largest market share in 2019, due to rising investments by major companies to develop technologically advanced products as well as the repetitive use of consumables. Consumables are further classified into reagents & kits, disposables, and beads. On the other hand, the instruments segment is anticipated to grow at the fastest growth rate over the forecast period, owing to advancements in products such as flow cytometers, centrifuges, magnetic-activated cell separator systems, and filtration systems. The innovations in instruments provide efficient cell separation in diagnostics, research, and other applications.

Geographical Analysis

North America region holds the largest market share of the global cell isolation market

North America region is dominating the global cell isolation market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure for life science research, the large presence of major players focusing on the development of novel treatments, and rising prevalence of cancer in this region. For instance, according to the estimates of the GLOBOCAN in 2020, there were an estimated 2,281,658 new cancer cases diagnosed and 612,390 deaths due to cancer in the United States. The Canadian Cancer Society (CCS) estimated that in 2020, approximately 29,800 Canadians would be diagnosed with lung cancer. Represents 13% of all new cancer cases. About 21,200 Canadians are expected to die from lung cancer. Means 25% of all cancer deaths in 2020. In addition, increasing government support for cancer and stem cell research and the expansion of biotechnology and biopharmaceutical industries globally are contributing to the growth of the market. In April 2018, STEMCELL Technologies announced a US$ 45 million joint agreement between the governments of Canada and British Columbia to help the company build an advanced manufacturing facility.

Competitive Landscape

The global cell isolation market is fragmented with major players dominating the market. Some of the major players contributing to the growth of the cell isolation market are Becton Dickinson and Company, Beckman Coulter, Inc., GE Healthcare, Merck KgaA, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., among others. The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Cell Isolation market globally. For instance,

In November 2019, MicroMedicine, Inc., a life sciences technology company, launched its patented one-of-a-kind white blood cell isolation technology, the Sorterra Cell Isolation System. This new automated technology gently and reliably isolates white blood cells from human peripheral blood using microfluidic channels without the use of centrifugation or labelling. Sorterra is intended for use in research and development and clinical research labs. Global Cell Isolation Market – Key Companies to Watch

Bio-Rad Laboratories

Overview: Bio-Rad Laboratories, Inc. is an American company that continued to produce innovative and useful products in the healthcare industry that assist life science researchers in accelerating the discovery process, and medical diagnostic labs obtain faster better results.

Product Portfolio: Bio-Plex Multiplex System- The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples.

The global cell isolation market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.